Home > Healthcare > Medical Devices > Diagnostic Devices > Preterm Birth Diagnostic Test Kits Market

Preterm Birth Diagnostic Test Kits Market Size

  • Report ID: GMI4044
  • Published Date: May 2023
  • Report Format: PDF

Preterm Birth Diagnostic Test Kits Market Size

Preterm Birth Diagnostic Test Kits Market size was valued at over USD 419 million in 2022 and is anticipated to grow at a CAGR of over 7.4% between 2023 and 2032. Preterm birth diagnostic test kits are medical devices or tools used to assess the risk of preterm birth in pregnant women. These tests help healthcare providers identify women that are at elevated risk of delivering their babies before 37 weeks of gestation. Additionally, the high incidence of preterm births is accelerating market growth.

 

Moreover, increasing awareness helps pregnant women, families, and healthcare providers recognize the signs and symptoms of preterm labor. Early recognition allows for prompt medical intervention, potentially preventing or managing preterm birth more effectively. Additionally, increased awareness can drive advocacy efforts aimed at improving healthcare policies, funding, and research focused on preterm birth prevention, treatment, and long-term outcomes. It helps foster collaboration among healthcare professionals, policymakers, and community organizations to address the challenges associated with preterm births, thereby augmenting preterm birth diagnostic test kits market growth. In addition, several market players are emphasizing on research and development activities for the development of novel preterm birth diagnostic test kits.

 

 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for preterm birth diagnostic test kits was valued at over USD 419 million in 2022 and is projected to reach more than USD 856 million by 2032, owing to high incidence of preterm births, along with increasing awareness about early detection of fetal anomalies.

Fetal fibronectin test kits (fFN) segment held the largest revenue size over USD 197 million in 2022 and will grow significantly through 2032, on account of high sensitivity of the test in detecting the presence of fetal fibronectin, a protein that acts as a biomarker for preterm birth.

U.S. market for preterm birth diagnostic test kits accounted for more than USD 158 million in 2022 and will gather more than USD 344 million by 2032. The affordability of preterm birth diagnostic test kits and ongoing technological developments are primarily responsible for the regional market growth.

Abbott, Creative Diagnostics, Clinical Innovations, Hologic, IQ Products, Qiagen, Medixbiochemica, Biosynex, CooperSurgical Inc, Sera Progonstics, and Stryker Corporation among others.

Preterm Birth Diagnostic Test Kits Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 277
  • Countries covered: 32
  • Pages: 200
 Download Free Sample